Treat HRT/TRT as a new clinical service line — not as a new membership package. Before marketing it, define the prescribing structure, medication pathway, patient evaluation, staffing, controlled-substance responsibilities, documentation, escalation, and quality-review plan. Testosterone’s Schedule III status makes the controlled-substance workflow a core part of the build.
Open the full explanation3 sections and primary sources
What is a practical sequence for adding an HRT, BHRT, or TRT line?
Define the business opportunity (men’s health, menopause care, longevity, retention); define the exact service (TRT, menopausal HRT, compounded BHRT, injections, transdermals, pellets) rather than “we’re adding hormones”; identify the prescriber model and controlled-substance authority; build the medication pathway (commercial vs compounded, pharmacy, dispensing, onsite administration, inventory, controlled-substance custody); build the operating model; then prepare the clinic for launch.
MFMD’s service-line development role
MFMD helps an existing brick-and-mortar practice evaluate and structure the clinical side — service concept, feasibility, physician-governance structure, prescribing model, provider/staff roles, pharmacy/sourcing, controlled-substance workflow, documentation and escalation, implementation planning, and physician review before launch. This is clinical service-line development, not AHCA licensure consulting.
Owner takeaway
Build the clinical service line before you sell the membership. See Add a Service Line to start.